ABBV
AbbVie Inc
264.40$
-0.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 58.4% | 30.8% | 24.5% | 30.0% | 28.6% | 55.6% | 16.1% | 19.1% | 20.5% | 24.5% | 18.9% | 21.7% | |
| 30.3% | 15.8% | 7.7% | 13.1% | 12.3% | 44.8% | 5.6% | 6.7% | 6.6% | 9.5% | 4.1% | 3.9% | |
| 30.4% | 15.8% | 9.7% | 13.8% | 13.6% | 44.8% | 5.6% | 6.7% | 6.6% | 9.5% | 4.1% | 3.9% | |
| 13.6% | 8.9% | 7.2% | 7.2% | 9.1% | 6.1% | 5.9% | 6.8% | 8.1% | 8.3% | 8.1% | 9.4% | |
| 4.1% | 3.2% | 2.2% | 2.3% | 2.7% | 2.0% | 2.2% | 2.1% | 2.6% | 3.0% | 3.1% | 3.7% | |
| 9.0% | 4.8% | 3.9% | 4.0% | 4.9% | 3.3% | 3.5% | 3.5% | 3.6% | – | – | – | |
| 21.3% | 24.8% | 23.3% | 22.3% | 26.4% | 17.5% | 22.0% | 22.1% | 23.2% | 24.0% | 25.9% | 26.6% | |
| 5.5% | 37.2% | 43.7% | 38.9% | 35.8% | 20.9% | 55.0% | 51.8% | 48.6% | 41.3% | 44.4% | 39.3% | |
| 93.7% | 92.6% | 93.0% | 92.8% | 114.2% | 109.2% | 91.3% | 89.5% | 87.5% | 92.3% | 97.5% | 102.4% | |
| 41.4% | 20.5% | 14.8% | 23.5% | 29.0% | 17.5% | 19.0% | 24.0% | 21.3% | 28.1% | 28.7% | 32.3% | |
| 16.1% | 4.6% | 0.6% | 9.1% | 8.9% | 4.2% | 5.8% | 8.6% | 3.1% | 5.3% | 5.0% | 6.5% | |
| 5.1% | 3.0% | 2.1% | 2.1% | 2.6% | 1.6% | 1.5% | 2.0% | 2.1% | 2.7% | 2.2% | 2.7% | |
| 38.4% | 55.1% | 55.1% | 43.7% | 59.0% | 70.7% | 51.5% | 43.8% | 42.6% | 38.7% | 44.6% | 44.0% | |
| 6.3% | 7.4% | 7.0% | 7.2% | -14.2% | -9.2% | 8.7% | 10.5% | 12.5% | 7.7% | 2.5% | -2.4% | |
| 1.9% | 4.2% | 6.6% | 7.7% | 5.7% | 5.3% | 0.7% | 2.1% | 3.4% | -0.7% | -5.8% | -11.6% | |
| 5.9% | 3.1% | 2.5% | 2.3% | 2.6% | 1.7% | 1.1% | 1.2% | 1.3% | 1.3% | 1.3% | 1.3% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.